Clinical Trial

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

Study acronym: MDS-QUAL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Observational study to evaluate changes in quality of life (QoL) in patients diagnosed with low risk MDS who are red blood cell (abc) transfusion dependent. Changes in QoL will be correlated with patient cardiorespiratory function. Cardiac biomarkers and plasma cytokines will also be evaluated.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-24.
Trial Details
NCT Number NCT06614595
Lead Sponsor Fundación para la Investigación Biosanitaria del Principado de Asturias
Collaborators: Hospital Universitario Central de Asturias
Conditions Low Risk Myelodysplastic Syndromes
Enrollment 30 participants
Start Date 2024-09-20
Primary Completion 2025-12-20 (estimated)
Study Completion 2025-12-21 (estimated)
Updated on ClinicalTrials.gov 2024-09-27